Qtron Investments’s Bristol-Myers Squibb BMY Stock Holding History

Qtron Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Buy	29,328 +9,629	+49%	+$553K	0.23%	77
2026 Q1	$1.19M	Buy	19,699 +15	+0.1%	+$874	0.16%	150
2025 Q4	$1.06M	Buy	19,684 +4,002	+26%	+$193K	0.14%	169
2025 Q3	$707K	Sell	15,682 -15,112	-49%	-$706K	0.09%	263
2025 Q2	$1.43M	Hold	30,794	–	–	0.18%	128
2025 Q1	$1.88M	Buy	30,794 +10,177	+49%	+$593K	0.28%	70
2024 Q4	$1.17M	Buy	20,617 +2,033	+11%	+$114K	0.16%	143
2024 Q3	$962K	Hold	18,584	–	–	0.13%	216
2024 Q2	$772K	Sell	18,584 -12,668	-41%	-$567K	0.11%	218
2024 Q1	$1.69M	Buy	31,252 +10,469	+50%	+$533K	0.24%	89
2023 Q4	$1.07M	Buy	20,783 +7,484	+56%	+$393K	0.17%	142
2023 Q3	$772K	Sell	13,299 -6,883	-34%	-$422K	0.15%	195
2023 Q2	$1.29M	Sell	20,182 -5,149	-20%	-$345K	0.24%	93
2023 Q1	$1.76M	Hold	25,331	–	–	0.36%	62
2022 Q4	$1.82M	Buy	25,331 +7,842	+45%	+$591K	0.38%	58
2022 Q3	$1.24M	Sell	17,489 -3,594	-17%	-$261K	0.31%	74
2022 Q2	$1.62M	Hold	21,083	–	–	0.36%	63
2022 Q1	$1.54M	Buy	+21,083	New	+$1.42M	0.34%	64
2021 Q4	–	Sell	-4,100	Closed	-$243K	–	334
2021 Q3	$243K	Sell	4,100 -6,076	-60%	-$400K	0.07%	268
2021 Q2	$680K	Sell	10,176 -5,302	-34%	-$346K	0.17%	179
2021 Q1	$977K	Buy	15,478 +1,509	+11%	+$93.9K	0.27%	87
2020 Q4	$866K	Hold	13,969	–	–	0.23%	101
2020 Q3	$842K	Hold	13,969	–	–	0.29%	72
2020 Q2	$821K	Sell	13,969 -8,648	-38%	-$517K	0.33%	68
2020 Q1	$1.26M	Buy	22,617 +1,197	+6%	+$73.2K	0.76%	20
2019 Q4	$1.38M	Buy	+21,420	New	+$1.23M	0.79%	23
2019 Q1	–	Sell	-4,365	Closed	-$227K	–	198
2018 Q4	$227K	Buy	+4,365	New	+$235K	0.17%	158

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Qtron Investments's BMY Position: Q2 2026 in Review

Qtron Investments increased its Bristol-Myers Squibb (BMY) stake by 49% in Q2 2026, buying an estimated $553K and bringing the position to 29,328 shares worth $1.69M. The position accounts for 0.23% of the portfolio, ranked #77.

Qtron Investments first reported a position in BMY in Q4 2018 and has held it in 27 quarters since. The position peaked at $1.88M in Q1 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Qtron Investments held 29,328 shares of Bristol-Myers Squibb worth $1.69M as of Q2 2026.
Qtron Investments bought 9,629 Bristol-Myers Squibb shares in Q2 2026, an estimated $553K.
Bristol-Myers Squibb made up 0.23% of Qtron Investments's portfolio in Q2 2026, its #77 holding.
Qtron Investments first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 27 quarters since.
Qtron Investments's Bristol-Myers Squibb position peaked at $1.88M in Q1 2025.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.